Medscape ✓

@Medscape · New York · joined 21 Oct 2008

Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.

286 706Followers

34 189Following

76 324Posts total

11.9KViews on collected posts

Postingan terbaru

Medscape ✓@Medscape5 Sep

Medicare’s expansion of coverage for A1c for diabetes screening in 2024 was followed by significant increases in use of the test and detection of prediabetes, new data showed. “This is the first study I’m aware of that specifically looks at how the testing patterns changed http 525 views · 0 likes · 0 reposts · 1 replies Open on X →

Medscape ✓@Medscape4 Sep

A new digital tool, https://t.co/Wx3zcRJYOm, developed by a multidisciplinary team of experts, assessed more than 30 potential contributors to obesity across seven categories. Initial data from its Dutch predecessor tool, completed by over 62,000 adults, found more than 90% had h 933 views · 0 likes · 0 reposts · 0 replies Open on X →

Medscape ✓@Medscape4 Sep

Federal and state regulators are drawing new boundaries around medical AI, from how the tools are vetted to who bears responsibility when they fail. Tap the link to read more: https://t.co/p5pj20vbLu https://t.co/NWYehWlndQ 1K views · 2 likes · 1 reposts · 0 replies Open on X →

Medscape ✓@Medscape4 Sep

Updated migraine prevention guidance incorporates calcitonin gene-related peptide (CGRP)-targeted therapies and places greater emphasis on individualized treatment selection based on patient priorities. Developed by the American Academy of Neurology (AAN) and American Headache h 1.9K views · 11 likes · 4 reposts · 3 replies Open on X →

Medscape ✓@Medscape4 Sep

What happens when B-cells misfire in IgA nephropathy (IgAN)? Join us for an honest, open discussion on the immune system's role in IgAN, progression risks, and new insights. Don't miss this candid conversation! https://t.co/CRKIaqfgjV https://t.co/Cus0attI1f 1.5K views · 6 likes · 2 reposts · 1 replies Open on X →

Medscape ✓@Medscape3 Sep

There’s a conversation oncologists describe as one of the hardest in medicine, and it’s not about delivering a grim diagnosis. “There’s nothing more anguishing than looking at a patient and telling them that we know how to treat their cancer, and that the treatment is quite http 611 views · 5 likes · 0 reposts · 0 replies Open on X →

Medscape ✓@Medscape3 Sep

Cardio is taking a bit of a hit these days as strength training edges itself into the spotlight. While the latter is absolutely deserving attention (and its rise in the cultural conversation is long overdue), it shouldn’t be at the expense of cardio. Aerobic activity has indeed 917 views · 4 likes · 0 reposts · 0 replies Open on X →

Medscape ✓@Medscape3 Sep

While nasal strips increase airflow, research shows they provide no significant medical improvement compared to placebos for sleep or snoring. Dr. Christopher Labos explores the research. https://t.co/P0AIfM4V4I 1.7K views · 5 likes · 0 reposts · 0 replies Open on X →

Medscape ✓@Medscape3 Sep

The Flu Fighters: Back-To-School Basics to Foster Caregiver Confidence in Vaccines https://t.co/6MqRTHd95c 1.4K views · 5 likes · 0 reposts · 0 replies Open on X →

Medscape ✓@Medscape3 Sep

"Neurological health and psychiatric well-being are intrinsically linked in epilepsy.” — Dr. Bettina Schmitz. Deepen your comorbidity screening protocols with our modules. https://t.co/DCzMsNXBwy https://t.co/kF5MZhfExa 1.4K views · 3 likes · 2 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

10 postingan dari 90 hari terakhir, dibandingkan dengan rentang 100K–1M pengikut. di bawah akun sekelasnya baik pada jangkauan maupun interaksi.

Median tayangan1 189akun ini5 983median untuk 100K–1M

Jangkauan, %0.41%akun ini1.49%median untuk 100K–1M

Interaksi, %0.36%akun ini0.93%median untuk 100K–1M

Metrik	Akun ini	Median untuk 100K–1M	Rasio
Median tayangan per postingan	1 189	5 983	0.20×
Jangkauan (tayangan ÷ pengikut)	0.41%	1.49%	0.28×
Tingkat interaksi	0.36%	0.93%	0.39×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.4K3 Sep

1.4K

1.7K

917

611

1.5K4 Sep

1.9K

933

5255 Sep

Last 10 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.37%3 Sep

0.36%

0.29%

0.44%

0.82%

0.58%4 Sep

0.97%

0.30%

0.00%

0.19%5 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes67.2%41 in total

Reposts14.8%9 in total

Replies8.2%5 in total

Bookmarks9.8%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Postingan terbaru

Dibandingkan akun berukuran sama

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Akun serupa